London Co. of Virginia lessened its holdings in Ingevity Corporation (NYSE:NGVT – Free Report) by 99.0% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 4,428 shares of the company’s stock after selling 444,342 shares during the period. London Co. of Virginia’s holdings in Ingevity were worth $315,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Millennium Management LLC increased its holdings in Ingevity by 1.3% during the third quarter. Millennium Management LLC now owns 1,189,524 shares of the company’s stock valued at $65,650,000 after buying an additional 15,562 shares during the period. Royce & Associates LP lifted its holdings in Ingevity by 7.7% during the fourth quarter. Royce & Associates LP now owns 1,111,158 shares of the company’s stock worth $65,758,000 after buying an additional 79,059 shares during the period. Brown Advisory Inc. boosted its position in Ingevity by 15.4% during the 4th quarter. Brown Advisory Inc. now owns 1,040,944 shares of the company’s stock valued at $61,603,000 after acquiring an additional 138,859 shares in the last quarter. Simcoe Capital Management LLC increased its holdings in shares of Ingevity by 9.4% in the 4th quarter. Simcoe Capital Management LLC now owns 1,020,945 shares of the company’s stock valued at $60,420,000 after acquiring an additional 87,490 shares during the period. Finally, Victory Capital Management Inc. increased its holdings in shares of Ingevity by 7.4% in the 4th quarter. Victory Capital Management Inc. now owns 867,915 shares of the company’s stock valued at $51,363,000 after acquiring an additional 60,163 shares during the period. 91.59% of the stock is currently owned by institutional investors.
Insider Transactions at Ingevity
In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the sale, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.88% of the stock is owned by corporate insiders.
Ingevity Price Performance
Ingevity (NYSE:NGVT – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.84 by $0.31. The firm had revenue of $258.00 million during the quarter, compared to analyst estimates of $254.73 million. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The business’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.01 EPS. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. Analysts forecast that Ingevity Corporation will post 5.05 EPS for the current fiscal year.
Analyst Ratings Changes
NGVT has been the topic of a number of recent research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a research report on Friday, July 17th. Wall Street Zen upgraded shares of Ingevity from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 7th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $80.00.
Check Out Our Latest Report on Ingevity
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Featured Stories
- Five stocks we like better than Ingevity
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT – Free Report).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
